The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1604
ISSUE1604
August 10, 2020
IV Artesunate for Severe Malaria
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
IV Artesunate for Severe Malaria
August 10, 2020 (Issue: 1604)
Artesunate for injection (Amivas LLC), a semi-synthetic
artemisinin derivative, is now approved
by the FDA for initial (induction) treatment of severe
malaria in children and adults. It has been available
from the CDC on a compassionate use basis...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.